{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:20:10Z","timestamp":1773832810445,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12325-025-03473-4","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T07:23:55Z","timestamp":1769498635000},"page":"1255-1273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a Novel Patient-Reported Outcome Diary to Capture and Monitor Home-Managed Pain Crises in Patients with Sickle Cell Disease"],"prefix":"10.1007","volume":"43","author":[{"given":"James","family":"Turnbull","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betsy","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane","family":"Myrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7480-1439","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Bascle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2122-6813","authenticated-orcid":false,"given":"Ahmed","family":"Daak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyran","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1889-8931","authenticated-orcid":false,"given":"Joshua","family":"Maher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"3473_CR1","doi-asserted-by":"publisher","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","volume":"4","author":"GJ Kato","year":"2018","unstructured":"Kato GJ, Piel FB, Reid CD, et al. Sickle cell disease. Nat Rev Dis Primers. 2018;4:18010.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"3473_CR2","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","volume":"10","author":"AM Thomson","year":"2023","unstructured":"Thomson AM, McHugh TA, Oron AP, et al. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000\u20132021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematol. 2023;10(8):e585\u201399.","journal-title":"Lancet Haematol"},{"issue":"Supplement 1","key":"3473_CR3","doi-asserted-by":"publisher","first-page":"5353","DOI":"10.1182\/blood-2024-211136","volume":"144","author":"K Olaniran","year":"2024","unstructured":"Olaniran K, Nero AC, Turer R. Sickle cell disease prevalence, social vulnerability, and rural-urban commuting area: a national snapshot from electronic medical data. Blood. 2024;144(Supplement 1):5353.","journal-title":"Blood"},{"key":"3473_CR4","unstructured":"United States Centers for Disease Control and Prevention. Data and Statistics on Sickle Cell Disease. 2024. https:\/\/www.cdc.gov\/sickle-cell\/data\/index.html. Accessed 19 Mar 2025."},{"issue":"2","key":"3473_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijns5020020","volume":"5","author":"BPD Inusa","year":"2019","unstructured":"Inusa BPD, Hsu LL, Kohli N, et al. Sickle cell disease-genetics, pathophysiology, clinical presentation and treatment. Int J Neonatal Screen. 2019;5(2):20.","journal-title":"Int J Neonatal Screen"},{"issue":"1","key":"3473_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.2022.10233","volume":"328","author":"PL Kavanagh","year":"2022","unstructured":"Kavanagh PL, Fasipe TA, Wun T. Sickle cell disease: a review. JAMA. 2022;328(1):57\u201368.","journal-title":"JAMA"},{"key":"3473_CR7","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1182\/blood-2024-211906","volume":"144","author":"JA Afranie-Sakyi","year":"2024","unstructured":"Afranie-Sakyi JA, Karimi M, Bozzo J, et al. Screening for cognitive impairment and depression in sickle cell disease: how are we doing? Blood. 2024;144:2249.","journal-title":"Blood"},{"issue":"4","key":"3473_CR8","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.chest.2015.12.016","volume":"149","author":"EM Novelli","year":"2016","unstructured":"Novelli EM, Gladwin MT. Crises in sickle cell disease. Chest. 2016;149(4):1082\u201393.","journal-title":"Chest"},{"key":"3473_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/2040620720955000","volume":"11","author":"I Osunkwo","year":"2020","unstructured":"Osunkwo I, Manwani D, Kanter J. Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease. Ther Adv Hematol. 2020;11:2040620720955000.","journal-title":"Ther Adv Hematol"},{"issue":"3","key":"3473_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/ejh.13430","volume":"105","author":"DS Darbari","year":"2020","unstructured":"Darbari DS, Sheehan VA, Ballas SK. The vaso-occlusive pain crisis in sickle cell disease: definition, pathophysiology, and management. Eur J Haematol. 2020;105(3):237\u201346.","journal-title":"Eur J Haematol"},{"issue":"7","key":"3473_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214355","volume":"14","author":"N Shah","year":"2019","unstructured":"Shah N, Bhor M, Xie L, et al. Sickle cell disease complications: prevalence and resource utilization. PLoS ONE. 2019;14(7):e0214355.","journal-title":"PLoS ONE"},{"issue":"1","key":"3473_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/bjh.19829","volume":"206","author":"T Seth","year":"2025","unstructured":"Seth T, Udupi S, Jain S, et al. Burden of vaso-occlusive crisis, its management and impact on quality of life of Indian sickle cell disease patients. Br J Haematol. 2025;206(1):296\u2013309.","journal-title":"Br J Haematol"},{"issue":"6","key":"3473_CR13","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s11136-019-02412-5","volume":"29","author":"AA Rizio","year":"2020","unstructured":"Rizio AA, Bhor M, Lin X, et al. The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease. Qual Life Res. 2020;29(6):1533\u201347.","journal-title":"Qual Life Res"},{"key":"3473_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2024.101194","volume":"65","author":"P Telfer","year":"2024","unstructured":"Telfer P, Anie KA, Kotsiopoulou S, et al. The acute pain crisis in sickle cell disease: what can be done to improve outcomes? Blood Rev. 2024;65:101194.","journal-title":"Blood Rev"},{"issue":"12","key":"3473_CR15","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","volume":"4","author":"AM Brandow","year":"2020","unstructured":"Brandow AM, Carroll CP, Creary S, et al. American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Adv. 2020;4(12):2656\u2013701.","journal-title":"Blood Adv"},{"key":"3473_CR16","unstructured":"American Society of Hematology. Joint FDA\/ASH Led Initiative Highlights Importance of Using Patient Reported Outcomes and Biomarkers in Clinical Trials to Advance SCD Therapies. 2019. https:\/\/www.sicklecelldisease.org\/2019\/12\/13\/ash-and-fda-unveil-new-recommendations-to-guide-clinical-development-of-sickle-cell-disease-therapies\/. Accessed 19 Mar 2025."},{"issue":"11","key":"3473_CR17","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1080\/17474086.2020.1830370","volume":"13","author":"SA Singh","year":"2020","unstructured":"Singh SA, Bakshi N, Mahajan P, Morris CR. What is the future of patient-reported outcomes in sickle-cell disease? Expert Rev Hematol. 2020;13(11):1165\u201373.","journal-title":"Expert Rev Hematol"},{"key":"3473_CR18","unstructured":"United States Food and Drug Administration. Patient-focused drug development: selecting, developing, or modifying fit-for-purpose clinical outcome assessments guidance for industry, Food and Drug Administration staff, and other stakeholders. 2022. https:\/\/www.fda.gov\/media\/159500\/download. Accessed 19 Mar 2025."},{"issue":"1","key":"3473_CR19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s13023-021-02096-6","volume":"16","author":"AU Zaidi","year":"2021","unstructured":"Zaidi AU, Glaros AK, Lee S, et al. A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease. Orphanet J Rare Dis. 2021;16(1):460.","journal-title":"Orphanet J Rare Dis"},{"issue":"23","key":"3473_CR20","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1182\/bloodadvances.2019000882","volume":"3","author":"AT Farrell","year":"2019","unstructured":"Farrell AT, Panepinto J, Carroll CP, et al. End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain. Blood Adv. 2019;3(23):3982\u20134001.","journal-title":"Blood Adv"},{"issue":"3","key":"3473_CR21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s43441-025-00767-1","volume":"59","author":"L Andersen","year":"2025","unstructured":"Andersen L, Williams M, Pease S, et al. An evaluation of time spent completing electronically collected patient-reported outcomes in clinical trials. Ther Innov Regul Sci. 2025;59(3):619\u201328.","journal-title":"Ther Innov Regul Sci"},{"issue":"2","key":"3473_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0885-3924(01)00407-9","volume":"23","author":"LS Franck","year":"2002","unstructured":"Franck LS, Treadwell M, Jacob E, Vichinsky E. Assessment of sickle cell pain in children and young adults using the adolescent pediatric pain tool. J Pain Symptom Manage. 2002;23(2):114\u201320.","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"3473_CR23","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/AJP.0000000000000195","volume":"31","author":"N Bakshi","year":"2015","unstructured":"Bakshi N, Stinson JN, Ross D, et al. Development, content validity, and user review of a web-based multidimensional pain diary for adolescent and young adults with sickle cell disease. Clin J Pain. 2015;31(6):580\u201390.","journal-title":"Clin J Pain"},{"issue":"1","key":"3473_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.pec.2019.08.021","volume":"103","author":"BW Dyal","year":"2020","unstructured":"Dyal BW, Ezenwa MO, Yao Y, et al. Randomized clinical trial of computerized PAINRelieveIt\u00ae for patients with sickle cell disease: PAINReportIt\u00ae and PAINUCope\u00ae. Patient Educ Couns. 2020;103(1):136\u201344.","journal-title":"Patient Educ Couns"},{"issue":"10","key":"3473_CR25","volume":"10","author":"MR Asnani","year":"2016","unstructured":"Asnani MR, Quimby KR, Bennett NR, Francis DK. Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications. Cochrane Database Syst Rev. 2016;10(10):CD011175.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"3473_CR26","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1007\/s12325-023-02545-7","volume":"40","author":"C Udeze","year":"2023","unstructured":"Udeze C, Evans KA, Yang Y, et al. Economic and clinical burden of managing sickle cell disease with recurrent vaso-occlusive crises in the United States. Adv Ther. 2023;40(8):3543\u201358.","journal-title":"Adv Ther"},{"issue":"4","key":"3473_CR27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/ajh.26063","volume":"96","author":"I Osunkwo","year":"2021","unstructured":"Osunkwo I, Andemariam B, Minniti CP, et al. Impact of sickle cell disease on patients\u2019 daily lives, symptoms reported, and disease management strategies: results from the international Sickle Cell World Assessment Survey (SWAY). Am J Hematol. 2021;96(4):404\u201317.","journal-title":"Am J Hematol"},{"key":"3473_CR28","volume-title":"Sickle Cell Crisis","author":"MB Borhade","year":"2025","unstructured":"Borhade MB, Patel P, Kondamudi NP. Sickle Cell Crisis. Treasure Island (FL): StatPearls; 2025."},{"key":"3473_CR29","unstructured":"National Heart, Lung, and Blood Institute. Sickle cell disease - Symptoms. 2024. https:\/\/www.nhlbi.nih.gov\/health\/sickle-cell-disease\/symptoms. Accessed 19 Mar 2025."},{"issue":"6","key":"3473_CR30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/jpepsy\/jsad019","volume":"48","author":"L Reinman","year":"2023","unstructured":"Reinman L, Schatz J, Johnston J, Bills S. Fatigue, stress appraisal, and emotional functioning among youth with sickle cell disease: a daily diary study. J Pediatr Psychol. 2023;48(6):562\u201371.","journal-title":"J Pediatr Psychol"},{"key":"3473_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2019.00140","volume":"6","author":"G Ceglie","year":"2019","unstructured":"Ceglie G, Di Mauro M, Tarissi De Jacobis I, et al. Gender-related differences in sickle cell disease in a pediatric cohort: a single-center retrospective study. Front Mol Biosci. 2019;6:140.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"3473_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10903-020-01015-4","volume":"23","author":"A Otufowora","year":"2021","unstructured":"Otufowora A, Liu Y, Young H, et al. Sex differences in willingness to participate in research based on study risk level among a community sample of African Americans in North Central Florida. J Immigr Minor Health. 2021;23(1):19\u201325.","journal-title":"J Immigr Minor Health"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03473-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03473-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03473-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:29:54Z","timestamp":1773822594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03473-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3473"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03473-4","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"James Turnbull, Betsy Williams, and Shane Myrick are employees of IQVIA, which received funding from Sanofi to conduct this study. St\u00e9phanie Bascle, Ahmed Daak, Kyran Jones, and Joshua Maher are employees or former employees of Sanofi, and may hold stock options in the company. Joshua Maher is currently Director, Patient Centred Outcomes, at Kyowa Kirin. Kyran Jones is currently at Biogen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. The study protocol was approved by the WCG institutional review board (IRB Tracking Number 20216266). All patients provided a completed informed consent form (adolescent patients provided assent to the study, with parents\/caregivers providing informed consent) before participating in the interviews, per the inclusion criteria. In the informed consent form, patients were informed that if this study were to be published, no identifiable information would be included.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}